Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden

Class:IdLiteratureReference:9713982
_displayNameRapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden
_timestamp2021-02-02 01:31:43
author[Person:9713981] Makimoto, Go
[Person:9713971] Ohashi, Kadoaki
[Person:9650844] Tomida, Shuta
[Person:9713987] Nishii, Kazuya
[Person:9713983] Matsubara, Takehiro
[Person:9713980] Kayatani, Hiroe
[Person:9713978] Higo, Hisao
[Person:9713984] Ninomiya, Kiichiro
[Person:9713974] Sato, Akiko
[Person:9713985] Watanabe, Hiromi
[Person:9713973] Kano, Hirohisa
[Person:9713986] Ninomiya, Takashi
[Person:9713979] Kubo, Toshio
[Person:9713975] Rai, Kammei
[Person:9710789] Ichihara, Eiki
[Person:9713977] Hotta, Katsuyuki
[Person:9713988] Tabata, Masahiro
[Person:9650833] Toyooka, Shinichi
[Person:6785376] Takata, Minoru
[Person:9713972] Maeda, Yoshinobu
[Person:9713970] Kiura, Katsuyuki
created[InstanceEdit:9713976] Rothfels, Karen, 2021-02-02
journalJ Thorac Oncol
pages2009-2018
pubMedIdentifier31374369
titleRapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden
volume14
year2019
(literatureReference)[DefinedSet:9700560] alectinib resistant ALK mutants [plasma membrane] [Homo sapiens]
[FailedReaction:9700656] alectinib resistant ALK mutants don't bind alectinib [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden (9713982)